tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Compare Contineum Therapeutics, Inc. Class A (CTNM) vs. Competitors

212 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$12.79
$495.70M
-5.28
167.01%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.05
$28.61M
-1.75
-79.04%
4 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$31.60
$1.82B
-12.77
263.22%
8 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$6.84
$633.67M
-9.36
189.16%
2 Buy
1 Hold
0 Sell
Moderate Buy
Immuneering
$5.50
$355.59M
-6.25
340.00%
5 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$7.31
$489.69M
-5.39
77.43%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
12.79
8.17
176.84%
TVRD
Tvardi Therapeutics
3.05
-11.65
-79.25%
CAPR
Capricor Therapeutics
31.60
22.20
236.17%
DRTS
Alpha Tau Medical Ltd
7.20
4.66
183.46%
IMRX
Immuneering
5.50
4.21
326.36%
ENGN
enGene Holdings
7.31
3.28
81.39%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts